UNICA IRIS Institutional Research Information System

MARONGIU, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 145.567
NA - Nord America 10.663
AS - Asia 3.977
SA - Sud America 790
AF - Africa 136
OC - Oceania 59
Continente sconosciuto - Info sul continente non disponibili 4
Totale 161.196
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 142.723
US - Stati Uniti d'America 10.478
SG - Singapore 1.658
CN - Cina 1.381
UA - Ucraina 670
SE - Svezia 642
BR - Brasile 625
DE - Germania 385
GB - Regno Unito 320
VN - Vietnam 283
FI - Finlandia 243
CA - Canada 115
FR - Francia 98
IN - India 96
KR - Corea 89
NL - Olanda 78
HK - Hong Kong 68
AR - Argentina 53
MX - Messico 50
RU - Federazione Russa 49
AU - Australia 48
ES - Italia 44
JP - Giappone 43
ZA - Sudafrica 43
BD - Bangladesh 42
TR - Turchia 41
AT - Austria 40
IE - Irlanda 36
IR - Iran 36
IQ - Iraq 35
PL - Polonia 33
ID - Indonesia 32
BE - Belgio 27
EC - Ecuador 26
EG - Egitto 25
PK - Pakistan 25
RO - Romania 24
CO - Colombia 21
MA - Marocco 18
MY - Malesia 18
CH - Svizzera 17
TW - Taiwan 17
HU - Ungheria 16
LT - Lituania 16
KE - Kenya 15
PH - Filippine 15
UZ - Uzbekistan 15
CL - Cile 14
PE - Perù 14
VE - Venezuela 14
CZ - Repubblica Ceca 13
PY - Paraguay 13
DK - Danimarca 12
AL - Albania 11
NZ - Nuova Zelanda 11
TH - Thailandia 11
AE - Emirati Arabi Uniti 10
BG - Bulgaria 10
RS - Serbia 10
BA - Bosnia-Erzegovina 9
ET - Etiopia 9
SA - Arabia Saudita 9
SD - Sudan 8
GR - Grecia 7
IL - Israele 7
AZ - Azerbaigian 5
CY - Cipro 5
DZ - Algeria 5
KZ - Kazakistan 5
PT - Portogallo 5
UY - Uruguay 5
EE - Estonia 4
GE - Georgia 4
JO - Giordania 4
MK - Macedonia 4
MT - Malta 4
NO - Norvegia 4
TN - Tunisia 4
CR - Costa Rica 3
HR - Croazia 3
KW - Kuwait 3
LU - Lussemburgo 3
PA - Panama 3
PR - Porto Rico 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BH - Bahrain 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EU - Europa 2
GF - Guiana Francese 2
GT - Guatemala 2
GY - Guiana 2
LB - Libano 2
LK - Sri Lanka 2
NG - Nigeria 2
NI - Nicaragua 2
NP - Nepal 2
Totale 161.174
Salva come PNG Salva come JPEG
Città #
Cagliari 138.605
Uta 3.426
Fairfield 1.365
Ashburn 849
Woodbridge 838
Houston 652
Chandler 644
Singapore 637
Dallas 623
Seattle 552
Wilmington 527
Boardman 505
Ann Arbor 463
Cambridge 449
Nyköping 442
Jacksonville 348
Beijing 289
Los Angeles 159
Dearborn 158
Boston 124
Santa Clara 116
Nanjing 111
Shanghai 111
Helsinki 110
The Dalles 108
New York 97
Buffalo 89
Hefei 86
San Diego 85
Ho Chi Minh City 81
Seoul 73
Milan 64
Dong Ket 56
São Paulo 56
Hebei 55
Toronto 52
Hanoi 50
Hong Kong 50
Munich 49
Shenyang 49
Guangzhou 46
Redwood City 46
London 44
Redondo Beach 41
Nanchang 36
Changsha 35
Rome 34
Jiaxing 33
Nuremberg 31
Tianjin 30
Verona 27
Frankfurt am Main 26
Brussels 25
Council Bluffs 25
Rio de Janeiro 25
Atlanta 24
Chicago 24
Dublin 24
Vienna 24
Warsaw 24
Orange 23
Millbury 22
Brandenburg 21
Johannesburg 21
Norwalk 20
Sassari 20
Stockholm 20
Tokyo 20
Denver 19
Brooklyn 18
Mexico City 18
Phoenix 18
Jinan 17
Mountain View 17
Turku 17
Redmond 16
Amsterdam 15
Ankara 15
Baghdad 15
Montreal 15
Ningbo 15
Tashkent 15
Belo Horizonte 14
Nairobi 13
Sydney 13
Auburn Hills 12
Central 12
Dhaka 12
Lahore 12
Manchester 12
Perth 12
San Francisco 12
Zhengzhou 12
Brasília 11
Chennai 11
Jakarta 11
Quartu Sant'elena 11
Saint Petersburg 11
Augusta 10
Budapest 10
Totale 154.435
Salva come PNG Salva come JPEG
Nome #
Vaping effects on asthma: results from a web survey and clinical investigation 2.933
Heterogeneity of Antiphospholipid Syndrome (APS) as Characterized by Brain Perfusion Techniques. Towards New Ways of Syndrome Characterization 2.754
The venous thromboembolic risk and the clot wave analysis: a useful relationship? 2.735
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review 2.720
Acquired factor VIII inhibitor and subsequent development of non-Hodgkin's lymphoma: a case report and review of the literature 2.542
Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatment. 2.537
Olanzapine-associated portal and superior mesenteric vein thrombosis 2.490
Are prothrombin time and clot waveform analysis useful in detecting a bleeding risk in liver cirrhosis? 2.407
Telemedicine can improve the quality of oral anticoagulation using portable devices and self-testing at home 2.298
Clot wave analysis and thromboembolic score in liver cirrhosis: two opposing phenomena 2.268
A retrospective cohort study of patients with pulmonary embolism: The impact of comorbidities on patient's outcome 2.164
Empathy and the Educational Approach to Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants 2.159
Underuse of anticoagulant therapy in hospitalized older patients: comment on the article of Wojszel et al 2.147
Management of Patients Taking Oral Anticoagulants Who Need Urgent Surgery for Hip Fracture 2.121
Pulmonary Thrombosis: A Clinical Pathological Entity Distinct from Pulmonary Embolism? 2.058
A Sardinian Family with Factor XI Deficiency 1.978
Clot Waveform Analysis: From Hypercoagulability to Hypocoagulability - A Review 1.973
Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience 1.968
Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study 1.909
A “Catastrophic” Heparin-Induced Thrombocytopenia 1.859
Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: A report of an autoptic case and review of the literature 1.796
Points of Care Testing International Normalized Ratio: Are They Useful for Monitoring Vitamin K Antagonists in a Thrombosis Center? 1.785
The hemostatic system. 1st Part 1.773
Fibrinogen and D-dimer levels in autoimmune subclinical and overt hypothyroidism and effects of levothyroxine treatment. 1.702
Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review 1.696
Epidemiology of infection with HIV-1 in Sardinia: a multicentre prospective study 1.666
Point-of-care testing INR: an overview 1.655
Has time come for the use of direct oral anticoagulants in the extended prophylaxis of venous thromboembolism in acutely ill medical patients? No 1.643
Pulmonary thrombosis in 2019-nCoV pneumonia? 1.638
Risk of reoperation in bioprosthetic valve patients with indication for longterm anticoagulation. Results from the observational retrospective multicentre PLECTRUM study 1.635
Uneven hepatic iron and phosphorus distribution in b-thalassemia 1.631
Optimizing tailored DIEP flap insetting in unilateral immediate free autologous breast reconstruction 1.610
Direct oral anticoagulants: what can we learn? 1.559
Mechanical prosthetic heart valves: Quality of anticoagulation and thromboembolic risk. The observational multicenter PLECTRUM study 1.556
Comparison of prothrombin time INR and clot waveform analysis performed with 129-mmol/L and 105-mmol/L citrate tubes 1.544
Immunological aspects in anti-HIV seronegative drug addicts. Correlation with the duration of heroin addiction and other viral infections 1.533
Fatal Cytopenia Induced by Low-Dose Methotrexate in Elderly With Rheumatoid Arthritis. Identification of Risk Factors 1.495
T lymphocyte subsets and viral infections in Sardinian parenteral drug abusers: relationship to HIV infection 1.461
The criteria of the Italian Federation of Thrombosis Centres on DOACs: a ‘‘real world’’ application in nonvalvular atrial fibrillation patients already on Vitamin K Antagonist 1.458
Thrombosis centres and AVKs monitoring in COVID-19 pandemic 1.431
Allele 4G of gene PAI-I associated with prothrombin mutation G20210A increases the risk for venous thrombosis 1.430
Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules in patients on oral anticoagulants 1.382
Fondaparinux: Should It Be Studied in Patients with COVID-19 Disease? 1.343
[Immunological aspects in anti-HIV seronegative drug addicts. Correlation with the duration of heroin addiction and other viral infections]. FT Aspetti immunologici nei tossicodipendenti anti-HIV sieronegativi. Correlazione con la durata di assunzione dell'eroina e con altre infezioni virali. 1.331
Direct inhibitors of thrombin and factor Xa: the importance of laboratory skills 1.321
A guide to oral anticoagulation 1.303
Warfarin prescription in patients with nonvalvular atrial fibrillation and one non-gender-related risk factor (CHA(2)DS(2)VASc 1 or 2): a treatment dilemma 1.260
The Italian START-Register on anticoagulation with focus on atrial fibrillation 1.247
Hyperhomocysteinemia: could the post-methionine oral loading test sometimes be avoided? 1.241
Antiphospholipid syndrome patients: The performance of Coagucheck XS in the monitoring of Vitamin K-Antagonists 1.225
A ‘‘two-step’’ educational approach for patients taking oral anticoagulants does not improve therapy control 1.204
Heparins and 2019-nCoV infection: a narrative review 1.199
Thyroid disorders and hypocoagulability 1.169
The predictive ability of bleeding risk stratification models in very old patients on vitaminK antagonist treatment for venous thromboembolism: results of the prospective collaborative EPICA study 1.161
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome 1.124
Vitamin K antagonists (coumarins), drugs used in the prevention and treatment of cardioembolism, deep vein thrombosis, and pulmonary embolism 1.122
Aspetti immunologici nei tossicodipendenti anti-HIV sieronegativi. Correlazione con la durata di assunzione dell’eroina e con altre infezioni virali 1.107
High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice 1.098
A routine silica-based activated partial thromboplastin time (Hemosil aPTT-SP (TM)) mostly excludes the presence of lupus anticoagulant 1.057
Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago 1.057
Rheumatoid arthritis and thrombosis 1.051
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA) 1.046
Fetal programming of atherosclerosis: may the barker hypothesis explain the susceptibility of a subset of patients to develop stroke or cardiac infarct? 1.034
Sampling variability in hepatic iron concentration in beta-thalassemia 994
Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful? 980
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 975
Plasma prekallikrein (Fletcher factor) in hepatic cirrhosis 975
Fetal programming of COVID-19: May the barker hypothesis explain the susceptibility of a subset of young adults to develop severe disease? 968
[Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy]. FT Effetto a breve termine della terapia con DL-carnitina per os ed L-carnitina e.v. nei pazienti uremici cronici in trattamento emodialitico. 954
Infectious agents including COVID-19 and the involvement of blood coagulation and fibrinolysis. A narrative review 953
Clot characterization by multidisciplinary approach: biochemical and imaging parameters in a hypocoagulative setting. A pilot study 953
Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy 920
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results: a reply to a rebuttal 912
Center-related determinants of VKA anticoagulation quality: A prospective, multicenter evaluation 897
Aortic vulnerability to COVID-19: Is the microvasculature of vasa vasorum a key factor? A case report and a review of the literature 845
Thrombotic sinusoiditis and local diffuse intrasinusoidal coagulation in the liver of subjects affected by COVID-19: The evidence from histology and scanning electron microscopy 835
null 824
Thromboembolic disease in patients with rheumatoid arthritis undergoing joint arthroplasty: Update on prophylaxes 818
Bleeding diathesis and gastro-duodenal ulcers in inherited cytosolic phospholipase-A2 alpha deficiency 809
Chronic intravascular coagulation in liver cirrhosis predicts a high hemorrhagic risk 806
Scanning electron microscopy of lung disease due to COVID-19 – a case report and a review of the literature 802
Amoxicillina-acido clavulanico ed anticoagulanti orali:un’associazione potenzialmente pericolosa 786
Chronic spontaneous urticaria: a low-grade disseminated intravascular coagulation only partially reversed by Omalizumab 783
Start-register (Survey on anticoagulated patients register): the first year of activity 774
null 772
Clinical history and gastrointestinal bleeding in patients taking oral anticoagulants 740
Management of special conditions in patients on vitamin K antagonists 723
D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study 719
null 679
Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation 677
Special indications for vitamin K antagonists: a review 664
null 644
null 633
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results 622
Questions and answers on the use of dabigatran and perpectives on the use of other new oral anticoagulants in patients with atrial fibrillation. A consensus document of the Italian Federation of Thrombosis Centers (FCSA) 620
null 617
null 616
Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2(V617F) mutation 591
Superior sagittal sinus thrombosis after lumbar puncture in a patient with T-cell lymphoblastic lymphoma: role of the prothrombin G20210A mutation and 4G/4G genotype 584
Incidence of a first thromboembolic event in asymptomatic carriers of high-risk antiphospholipid antibody profile: a multicenter prospective study 582
Totale 134.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 223.733
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 223.733
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202117.755 0 0 0 0 0 4.631 3.783 2.511 817 2.136 1.868 2.009
2021/20229.067 879 677 410 654 750 715 606 496 695 941 1.137 1.107
2022/202314.010 1.313 1.842 1.695 1.232 1.226 1.485 702 1.126 916 789 1.047 637
2023/202416.132 678 938 781 1.401 1.612 2.201 2.427 1.093 778 1.179 1.611 1.433
2024/202528.713 6.080 7.329 3.416 2.935 3.253 1.830 2.131 175 431 433 291 409
2025/20264.490 552 369 1.243 1.020 719 587 0 0 0 0 0 0
Totale 161.714